Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

NCT01407770 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-03-28

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x rays to kill tumor cells. Radiation therapy may cause skin reactions when patients are exposed to high-energy x rays. Studying the genetic pattern of patients before and after radiation therapy may help doctors prevent toxicity and plan the best treatment.

PURPOSE: This clinical trial studies genetic susceptibility to radiation-induced skin reactions in racial/ethnic groups of patients with breast cancer.

Conditions

Interventions

GENETIC

DNA analysis

Genetic

GENETIC

gene expression analysis

Genetic

OTHER

enzyme-linked immunosorbent assay

Genetic

OTHER

flow cytometry

Genetic

OTHER

laboratory biomarker analysis

Genetic

OTHER

questionnaire administration

Genetic

PROCEDURE

adjuvant therapy

Genetic

PROCEDURE

assessment of therapy complications

Genetic

PROCEDURE

quality-of-life assessment

Genetic

RADIATION

3-dimensional conformal radiation therapy

Genetic

RADIATION

breast irradiation

Genetic

RADIATION

external beam radiation therapy

Genetic

RADIATION

hypofractionated radiation therapy

Genetic

RADIATION

intensity-modulated radiation therapy

Genetic

RADIATION

whole breast irradiation

Genetic

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • James J. Urbanic, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-20
Primary Completion
2014-08-26
Completion
2014-08-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01407770 on ClinicalTrials.gov